Skip to main content
TipRanks
Go Ultimate75% OFF

Andros Pharmaceuticals Co., Ltd. (6917) Balance Sheet

Andros Pharmaceuticals Co., Ltd. Balance Sheet

Andros Pharmaceuticals Co., Ltd.'s total assets for Q2 2026 were NT$527.03M, a decrease of 5.71% from the previous quarter. TW:6917 total liabilities were NT$40.95M for the fiscal quarter, a 5.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 558.97MNT$ 441.48MNT$ 529.15MNT$ 329.60MNT$ 120.27M
NT$ 43.25MNT$ 47.31MNT$ 58.04MNT$ 50.12MNT$ 51.60M
NT$ 515.72MNT$ 394.17MNT$ 471.11MNT$ 279.48MNT$ 68.66M

Currency in TWD

Andros Pharmaceuticals Co., Ltd. Liabilities to Assets

0200M400M600M0 %15 %30 %45 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets